LinkedInCN HEALTHY FOOD TECH GROUP CORP (Ticker: UCFI)
Exchange: NASDAQ
Data as of: October 1, 2025
| Ticker | Exchange | Price (USD) | Change (%) | Volume |
|---|---|---|---|---|
| UCFI | NASDAQ | 5.90 | +44.25 | 773,516 |
Healthy Food by Brooke Lark
Introduction to the Company
CN Healthy Food Tech Group Corp is a newly public company listed on NASDAQ under the symbol UCFI. The firm emerged from a business combination between Iron Horse Acquisitions Corp (NASDAQ: IROH) and Rosey Sea Holdings Limited, the parent of Zhong Guo Liang Tou Group Limited (operating as China Food Investment). The combined entity is focused on the research, development, production, and sales of food biotechnology and healthy-living products, emphasizing green and nutritious consumption across Asia while seeking to expand internationally.
Corporate Structure and Workforce
Detailed disclosures regarding the company’s employee count and organizational structure have not been made available. Prior to the merger:
- Iron Horse Acquisitions Corp acted as a special purpose acquisition company (SPAC) with a leadership team specializing in deal origination and corporate finance.
- Zhong Guo Liang Tou Group Limited managed research, production, and sales divisions for health-oriented food products in Asia.
CN Healthy Food Tech Group Corp integrates these teams, combining the SPAC's experience in capital markets with expertise in food technology.
Recent Developments and News
- September 30, 2025: Nasdaq issued Equity Corporate Actions Alert #2025-540 confirming the completion of the business combination between Iron Horse Acquisitions Corp and Rosey Sea Holdings Limited. The effective date signifies CN Healthy Food Tech Group Corp’s entry into the public market.
- Business Combination Announcement: Representatives from Iron Horse and China Food Investment indicated that the completion of the merger positions the company for further development in health foods and biotechnology.
- Nasdaq Listing: Following the merger, UCFI shares began trading on NASDAQ, with a reported trading volume of over 773,000 shares during the debut session.
Financial and Strategic Analysis
The 44.25% increase in UCFI’s share price to $5.90 on October 1 reflects notable investor interest. Key strategic considerations include:
- Capital Structure: As a public company post-merger, CN Healthy Food Tech Group Corp has access to the SPAC’s $100 million in trust proceeds, typical for SPAC transactions, which may be utilized for expansion and research and development initiatives.
- Revenue Model: The integration of biotechnology R&D with manufacturing and distribution is designed to diversify revenue streams, including ingredient sales, finished-goods licensing, and online-offline retail partnerships.
- Growth Strategy: Management has indicated plans to enhance production capacity in China, utilize e-commerce channels, and evaluate selective acquisitions to expand its product portfolio.
Market Position and Industry Context
CN Healthy Food Tech Group Corp operates within two expanding markets:
- Functional Foods & Nutraceuticals: The global demand for health-focused food products is projected to grow at a mid-single-digit compound annual growth rate, supported by demographic trends and increased focus on wellness.
- Biotech Ingredients: Innovations in biotechnology facilitate the development of specialized ingredients (e.g., probiotics, plant-based proteins) that can command premium pricing.
Major competitors include global agribusiness and nutrition companies, such as Archer Daniels Midland (ADM), which has over 75 years of experience in human and animal nutrition solutions. CN Healthy Food Tech aims to establish a presence through an integrated “online-offline” approach, combining direct-to-consumer sales in Asia with traditional retail distribution channels.
tl;dr
On September 30, 2025, CN Healthy Food Tech Group Corp began trading on NASDAQ (UCFI) following its merger with Iron Horse Acquisitions Corp and Rosey Sea Holdings Limited, parent of China Food Investment. Shares closed at $5.90 on October 1, representing a 44.25% increase on a trading volume of 773,516. The company retains approximately $100 million in SPAC trust proceeds for research and development and to enhance manufacturing capabilities for food-biotechnology products. Upcoming initiatives include scaling production in China, expanding e-commerce partnerships, and pursuing strategic acquisitions in the health-food sector.
